About the Company
Science
Medications
Careers
Press Center
Pharmacovigilance
+7 (495) 684-43-33
РУ EN
+7 (495) 684-43-33
  • About the Company
  • Science
  • Medications
  • Careers
  • Press Center
  • Pharmacovigilance

    • Company News

    Материа Медика
    08.05.2013

    The trial of Anaferon for children in Vietnam

    The trial of Anaferon for children in Vietnam.
    Материа Медика
    24.04.2013

    GMP certificate

    GMP certificate
    Материа Медика
    23.04.2013

    Impaza medicine is registered in Mexico

    Impaza medicine is registered in Mexico.
    Материа Медика
    22.04.2013

    ISO 9001-2011 (ISO 9001:2008) Quality Management Systems - Audited and Certified

    ISO 9001-2011 (ISO 9001:2008) Quality Management Systems - Audited and Certified
    Материа Медика
    15.04.2013

    Impaza has been authorized in Mexico

    The drug for the treatment of erectile dysfunction Impaza has been authorized in Mexico
    Материа Медика
    27.12.2012

    Pharmaceutical company OOO "NPF "Materia Medica Holding" has obtained GMP certificates from Slovakia and Ukraine

    In October 2012, manufacturing unit of OOO "NPF "Materia Medica Holding" located in Chelyabinsk successfully completed the audit of State Administrations of Ukraine and Slovakia.
    Материа Медика
    06.02.2012

    Sensational findings on antiviral efficacy of Anaferon for children according to Antiviral Research Journal of International Society on Antiviral Research

    The results of the study of antiviral activity of Anaferon for children on experimental model of swine influenza have been published.
    Company News 29 - 35 из 56
     Начало | Пред. | 3 4 5 6 7 | След. | Конец